AI Articles and Analysis about Research and development

Explore articles and reports related to artificial intelligence for research and development, including drug development, discovery, legal research, and more.

Future of Drug Targeting – Lilly @2x-1-min

The Future of Drug Targeting and Clinical Development with Generative AI Tools – with Ramesh Durvasula of Eli Lilly

Lily is a pharmaceutical giant with a legacy dating back to its founding in 1876 by Colonel Eli Lilly. The company engages more than 9600 employees in research and development, with clinical research conducted in more than 55 countries. As of 2022, the company clocked a revenue of $28,541.4 million and made a net income of $6,244.8 million. 

AI at GSK@2x-min

Artificial Intelligence at GSK

GlaxoSmithKline (GSK) is a multinational pharmaceutical company headquartered in Brentford, UK. The company operates in over 150 countries. GSK offers a wide range of pharmaceutical products, vaccines, and consumer healthcare products, including over-the-counter medications, oral care and nutritional products.

AI at McKesson@2x-min

Artificial Intelligence at McKesson – Three Use Cases

Founded in 1833 and headquartered in Irving, Texas, since 2019, McKesson is a leading distributor of pharmaceuticals and medical supplies. They also provide health information technology and care management tools.

AI at Cardinal Health@2x-min

Artificial Intelligence at Cardinal Health – Two Use Cases

Cardinal Health is a global healthcare services company with a rich history and a strong focus on providing integrated solutions to the healthcare industry. Established in 1971, the company has become a leading player in the healthcare sector, offering a wide range of products, services, and technologies to enhance patient care, optimize supply chain efficiency, and drive value-based outcomes.

AI at Bosch@1x-min

Artificial Intelligence at Bosch

Bosch is a German multinational technology and engineering company headquartered in Gerlingen, Germany. Bosch manufactures products across various industries, including aerospace, automotive, energy and utilities, healthcare and others.

Strategic Adoption of Large Language Models and Generative AI – with Asif Hasan of Quantiph@2x

Strategic Adoption of Large Language Models and Generative AI – with Asif Hasan of Quantiphi

As nearly every American household has realized over the last year, large language models combined with generative AI abilities pose tremendous challenges and opportunities for enterprises of every shape and size. Just ask anyone who has heard of ChatGPT.

Overcoming Obstacles 
in Reaching ROI
for AI projects@2x

Overcoming Obstacles in Reaching ROI for AI Projects – with Fallon Gorman of NLP Logix

AI initiatives that cannot find ROI have no use in modern business. However, the path to ROI from enterprise-wide digital transformations is never a straight and narrow road. A pre-pandemic survey from MIT Sloan Management Review and Boston Consulting Group found that 70% of companies among those surveyed reported no value from their AI investments. 

002 – Creating Insurance Policies for AI Applications – with Munich Re’s Michael Berger

Creating Insurance Policies for AI Applications – with Munich Re’s Michael Berger

As AI becomes increasingly interwoven in the fabric of our everyday lives, the insurance sector is finding new business challenges and opportunities in all of the ways these emerging technologies bring increased risk - and security - to our lives.

Research and development

Explore articles and reports related to artificial intelligence for research and development, including drug development, discovery, legal research, and more.